SOX9 Antikörper (AA 400-509)

Produktnummer ABIN520382

Produktdetails anti-SOX9 Antikörper

Target: SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))

Bindungsspezifität: AA 400-509

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser SOX9 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP)

Verwendungszweck: Mouse monoclonal antibody raised against a partial recombinant SOX9.

Sequenz: EQLSPSHYSE QQQHSPQQIA YSPFNLPHYS PSYPPITRSQ YDYTDHQNSS SYYSHAAGQG TGLYSTFTYM NPAQRPMYTP IADTSGVPSI PQTHSPQHWE QPVYTQLTRP

Kreuzreaktivität: Human

Produktmerkmale: Antibody Reactive Against Recombinant Protein.

Immunogen: SOX9 (NP_000337, 400 a.a. ~ 509 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Klon: 3C10

Isotyp: IgG2a

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: In 1x PBS, pH 7.4

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-SOX9 Antikörper (ABIN520382)

Loebel, Czekanska, Bruderer, Salzmann, Alini, Stoddart: "In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio." in: Tissue engineering. Part A, Vol. 21, Issue 1-2, pp. 115-23, (2015) (PubMed).

Yun, Kim, Choe, Min, Lee, Jung, Oh, Kim: "Expression of cancer stem cell markers is more frequent in anaplastic thyroid carcinoma compared to papillary thyroid carcinoma and is related to adverse clinical outcome." in: Journal of clinical pathology, Vol. 67, Issue 2, pp. 125-33, (2014) (PubMed).

Hagel, Treszl, Fehlert, Harder, von Haxthausen, Kern, von Bueren, Kordes: "Supra- and infratentorial pediatric ependymomas differ significantly in NeuN, p75 and GFAP expression." in: Journal of neuro-oncology, Vol. 112, Issue 2, pp. 191-7, (2013) (PubMed).

Hodgin, Borczuk, Nasr, Markowitz, Nair, Martini, Eichinger, Vining, Berthier, Kretzler, DAgati: "A molecular profile of focal segmental glomerulosclerosis from formalin-fixed, paraffin-embedded tissue." in: The American journal of pathology, Vol. 177, Issue 4, pp. 1674-86, (2010) (PubMed).

Details zu SOX9

Target: SOX9 (SRY (Sex Determining Region Y)-Box 9 (SOX9))

Andere Bezeichnung: SOX9 (SOX9 Produkte)

Synonyme: CMD1 antikoerper, CMPD1 antikoerper, SRA1 antikoerper, LOC100227849 antikoerper, 2010306G03Rik antikoerper, AV220920 antikoerper, mKIAA4243 antikoerper, SOX-9 antikoerper, cmd1 antikoerper, cmpd1 antikoerper, sox-9 antikoerper, sox9 antikoerper, sox9-a antikoerper, sox9-b antikoerper, sox9b antikoerper, sra1 antikoerper, SRY-box 9 antikoerper, transcription factor SOX-9 antikoerper, SRY (sex determining region Y)-box 9 antikoerper, SRY box 9 antikoerper, SRY-box 9 L homeolog antikoerper, SOX9 antikoerper, LOC100227849 antikoerper, Sox9 antikoerper, sox9.L antikoerper

Hintergrund: Full Gene Name: SRY (sex determining region Y)-box 9
Synonyms: CMD1,CMPD1,SRA1

Gen-ID: 6662

NCBI Accession: NM_000346

Pathways: EGFR Signaling Pathway, Stem Cell Maintenance, Regulation of Muscle Cell Differentiation, Tube Formation, Skeletal Muscle Fiber Development